BCYC

Bicycle Therapeutics (BCYC)

About Bicycle Therapeutics (BCYC)

Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.

Details

Daily high

$5.66

Daily low

$5.36

Price at open

$5.44

52 Week High

$13.11

52 Week Low

$5.27

Market cap

282.6M

Dividend yield

0.00%

Volume

263,188

Avg. volume

398,326

P/E ratio

-1.56

Bicycle Therapeutics News